1. Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5 ‐positive DLBCL
- Author
-
Miyazaki, Kana, primary, Sakai, Rika, additional, Iwaki, Noriko, additional, Yamamoto, Go, additional, Murayama, Kayoko, additional, Nishikori, Momoko, additional, Sunami, Kazutaka, additional, Yoshida, Isao, additional, Yano, Hiroki, additional, Takahashi, Naoki, additional, Okamoto, Akinao, additional, Munemoto, Saori, additional, Sawazaki, Aiko, additional, Suehiro, Youko, additional, Fukuhara, Noriko, additional, Wake, Atsushi, additional, Arai, Ayako, additional, Masaki, Yasufumi, additional, Toyama, Kohtaro, additional, Yokoyama, Akihiro, additional, Tsunemine, Hiroko, additional, Hasegawa, Yuichi, additional, Matsumoto, Kenji, additional, Yamada, Tomomi, additional, Nishimura, Yuki, additional, Tamaru, Satoshi, additional, Asano, Naoko, additional, Miyawaki, Kohta, additional, Izutsu, Koji, additional, Kinoshita, Tomohiro, additional, Suzuki, Ritsuro, additional, Ohshima, Koichi, additional, Kato, Koji, additional, Katayama, Naoyuki, additional, and Yamaguchi, Motoko, additional
- Published
- 2023
- Full Text
- View/download PDF